What is a stock summary page? Click here for an overview.
Business Description
VBI Vaccines Inc
NAICS : 325412
SIC : 3741
ISIN : CA91822J1030
Compare
Compare
Traded in other countries / regions
VBIVQ.USALO9A.Germany Index Membership
Russell 3000Russell 2000 IPO Date
2016-05-09Description
VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | -0.07 | |||||
| Debt-to-Equity | -9.28 | |||||
| Debt-to-EBITDA | -0.7 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -15.1 | |||||
| Beneish M-Score | 17.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 56.3 | |||||
| 3-Year EBITDA Growth Rate | 2.1 | |||||
| 3-Year EPS without NRI Growth Rate | 13.9 | |||||
| 3-Year FCF Growth Rate | 15.6 | |||||
| 3-Year Book Growth Rate | -75.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 63.47 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 95.77 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.36 | |||||
| 9-Day RSI | 42.17 | |||||
| 14-Day RSI | 33.35 | |||||
| 3-1 Month Momentum % | -96.43 | |||||
| 6-1 Month Momentum % | -99.94 | |||||
| 12-1 Month Momentum % | -99.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.34 | |||||
| Quick Ratio | 0.21 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 247.68 | |||||
| Days Sales Outstanding | 9.11 | |||||
| Days Payable | 246.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -42.7 | |||||
| Shareholder Yield % | -40459.29 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -24.06 | |||||
| Operating Margin % | -505.33 | |||||
| Net Margin % | -881.79 | |||||
| FCF Margin % | -547.03 | |||||
| ROE % | -548.07 | |||||
| ROA % | -86.45 | |||||
| ROIC % | -48.25 | |||||
| 3-Year ROIIC % | -33.71 | |||||
| ROC (Joel Greenblatt) % | -601.05 | |||||
| ROCE % | -194.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.51 | |||||
| EV-to-EBITDA | -0.52 | |||||
| EV-to-Revenue | 4.05 | |||||
| EV-to-Forward-Revenue | 4.98 | |||||
| EV-to-FCF | -0.74 | |||||
| Earnings Yield (Greenblatt) % | -196.08 | |||||
| FCF Yield % | -367721.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VBIVQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VBI Vaccines Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9.411 | ||
| EPS (TTM) ($) | -6.927 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.69 | ||
| 3-Year Sortino Ratio | -1.6 | ||
| Volatility % | 147.64 | ||
| 14-Day RSI | 33.35 | ||
| 14-Day ATR ($) | 0.001119 | ||
| 20-Day SMA ($) | 0.000505 | ||
| 12-1 Month Momentum % | -99.92 | ||
| 52-Week Range ($) | 0.00001 - 1.35 | ||
| Shares Outstanding (Mil) | 28.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
VBI Vaccines Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
VBI Vaccines Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
VBI Vaccines Inc Frequently Asked Questions
What is VBI Vaccines Inc(VBIVQ)'s stock price today?
The current price of VBIVQ is $0.00. The 52 week high of VBIVQ is $1.35 and 52 week low is $0.00.
When is next earnings date of VBI Vaccines Inc(VBIVQ)?
The next earnings date of VBI Vaccines Inc(VBIVQ) is 2025-04-16 Est..
Does VBI Vaccines Inc(VBIVQ) pay dividends? If so, how much?
VBI Vaccines Inc(VBIVQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers